MARINELLI BUSILACCHI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 720
EU - Europa 396
AS - Asia 137
AF - Africa 21
SA - Sud America 6
Totale 1.280
Nazione #
US - Stati Uniti d'America 719
IT - Italia 201
CN - Cina 52
SG - Singapore 46
IE - Irlanda 42
SE - Svezia 41
UA - Ucraina 26
DE - Germania 20
GB - Regno Unito 15
HK - Hong Kong 15
CI - Costa d'Avorio 14
FR - Francia 13
RO - Romania 12
DK - Danimarca 7
MA - Marocco 7
NL - Olanda 7
BR - Brasile 6
FI - Finlandia 6
IN - India 6
KR - Corea 5
TR - Turchia 3
CH - Svizzera 2
IR - Iran 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
BE - Belgio 1
IQ - Iraq 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MX - Messico 1
PT - Portogallo 1
VN - Vietnam 1
Totale 1.280
Città #
Chandler 84
Fairfield 69
Boardman 56
Des Moines 52
New York 44
Dublin 42
Ashburn 41
Jacksonville 36
Woodbridge 33
Redmond 30
Seattle 30
Wilmington 28
Singapore 27
Houston 24
Centro 16
Marche 16
Rome 16
Hong Kong 15
Turin 15
Abidjan 14
Ancona 14
Cambridge 13
Brasov 12
Lawrence 12
Princeton 12
San Benedetto del Tronto 10
San Mateo 10
Guangzhou 8
Ann Arbor 7
Iesi 7
Los Angeles 7
San Diego 7
Cagliari 6
Milan 6
Beijing 5
London 5
Wuhan 5
Bristol 4
Falconara Marittima 4
Florence 4
Pune 4
Shanghai 4
Washington 4
Bologna 3
Dedham 3
Helsinki 3
Tolentino 3
Wuxi 3
Bangkok 2
Campobasso 2
Chiaravalle 2
Dallas 2
Fayetteville 2
Kilburn 2
Marsciano 2
Naples 2
Pesaro 2
Pescara 2
Varese 2
Visakhapatnam 2
Zola Predosa 2
Zurich 2
Acerra 1
Acquaviva Picena 1
Baku 1
Boston 1
Brussels 1
Campina Grande 1
Campogalliano 1
Cantu 1
Capanema 1
Cedar Knolls 1
Chicago 1
Chieti 1
Clifton 1
Dong Ket 1
Edison 1
Groningen 1
Hounslow 1
Jiaxing 1
Jinan 1
João Pessoa 1
Kish 1
Lisbon 1
Macerata 1
Monsampolo del Tronto 1
Montemarciano 1
Morrovalle 1
Nanjing 1
Nantong 1
New Bedfont 1
Nuremberg 1
Parrano 1
Porto 1
Presidente Getúlio 1
Qingdao 1
Redwood City 1
Riga 1
Ripa Teatina 1
Roseto degli Abruzzi 1
Totale 939
Nome #
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 154
Pre-eclampsia onset and SPARC: A possible involvement in placenta development. 140
null 100
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis 100
Apoptotic mechanism activated by blue light and cisplatinum in cutaneous squamous cell carcinoma cells 95
Basi cellulari e molecolari della Graft-Versus-Host Desease 93
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 91
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study 89
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 81
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 61
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 60
MiR-422a promotes adipogenesis via MeCP2 downregulation in human bone marrow mesenchymal stem cells 47
Modulation of matrix metalloproteases by ciliary neurotrophic factor in human placental development 43
Specific Anti-Nuclear Antibodies, Clinical Features and Outcome Following Treatment with Nilotinib In Patients with Chronic Graft-Versus-Host Disease. The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Sessions 36
Novel Translational Read-Through–Inducing Drugs as A Therapeutic Option for Shwachman-Diamond Syndrome 34
null 25
Bone Marrow Adipose Tissue 22
null 20
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells 18
A 50 Hz magnetic field influences the viability of breast cancer cells 96 h after exposure 14
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria) 13
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 7
Totale 1.343
Categoria #
all - tutte 7.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.517


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 0 0 0 5 5 6 2 10 19
2020/2021303 14 15 17 10 29 59 39 18 21 30 21 30
2021/2022107 0 12 5 1 1 8 11 6 9 15 9 30
2022/2023339 24 38 17 22 14 88 1 16 71 1 41 6
2023/2024259 23 2 12 26 32 63 12 18 4 9 14 44
2024/2025204 56 35 20 8 23 25 37 0 0 0 0 0
Totale 1.343